Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 10,762

Document Document Title
WO/2009/128521A1
Disclosed are: a compound having an excellent inhibitory activity on cysteine protease; and a pharmaceutical agent for the treatment or prevention of a disease selected from the group consisting of osteoporosis, osteoarthrosis deformans,...  
WO/2009/125606A1
Provided is a compound represented by formula (I) having a PAI-1 inhibiting action. [In formula (I), R1 represents an optionally substituted C6-10 aryl group etc., T represents a single bond etc., m is 0 or 1, when m is 0 G represents -N...  
WO/2009/125861A1
Disclosed are a compound having an outstanding cysteine protease inhibiting action, and medicaments for treating or preventing a disorder selected from a set comprising osteoporosis, osteoarthrosis deformans, rheumatoid arthritis, Paget'...  
WO/2009/123109A1
A photosensitive transparent resin composition which is reduced in the dependence on exposure illuminance and which can stably form patterns excellent in resolution with high retention of film thickness and nearly without scum; color fil...  
WO/2009/118292A1
The present invention provides a compound of formula (I):said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by a...  
WO/2009/120783A1
Compositions and uses thereof that inhibit HCV life cycle by inhibiting action of the HCV NS3/4A protease. An embodiment of the invention comprises a compound designated RS-2-19.  
WO/2009/116487A1
Disclosed is a method for producing a sulfone compound represented by formula (1), which comprises a step of obtaining a compound represented by formula (4) by reacting a compound represented by formula (3) with a chlorate or a bromate, ...  
WO/2009/114849A1
Asymmetric cyclopropanation of olefins with diazosulfones.  
WO/2009/113508A1
Disclosed is an acid having a fluorine-containing carbanion structure or a salt having a fluorine-containing carbanion structure, which is represented by general formula (1). By using a photoacid generator for chemically amplified resist...  
WO/2009/109483A1
Provided herein are compounds of the formula (I), as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing...  
WO/2009/109866A3
This invention relates to a process for the preparation of (3-trifluoromethylsulfonyl)-N-[4- methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamid e (formula (I)) starting from 4-methyl-2-nitro-aniline (formula (II)) through inter...  
WO/2009/106664A1
The invention relates to labelling agents containing a compound with a labelled molecule and a vinyl sulphone group. The invention also relates to the compounds, the method for obtaining same and the uses thereof in the marking of biomol...  
WO/2009/097684A1
The invention relates to a method for measuring the real temperature of a hot spot in an oil-containing electric apparatus, such as a power transformer. The electric apparatus is operated in predetermined and changeable operating conditi...  
WO/2009/096545A1
A diurethane compound R2(SO2)m(CH2)nOCONH-R1-NHCOO(CH2)n(SO2)mR2 is produced by a method in which a diamine compound H2NR1NH2 is reacted with a chloroformate compound ClCOO(CH2)n(SO2)mR2 or by a method in which a diisocyanate compound OC...  
WO/2009/092713A1
This invention relates to novel N-(2-methyl-phenyl-cyclopentyl)sulphonamide derivatives of formula (I) and salts thereof: wherein R1, R2, R3, R4, R5, R6, R7, R8, p, R9 and R10 are as defined in the description. The invention also relates...  
WO/2009/090663A1
The present invention relates to a novel crystalline polymorph of armodafinil. In another aspect the invention relates to an improved process for preparation of the novel polymorph of armodafinil.  
WO/2009/091704A3
Fluorine-free photoacid generators and photoresist compositions containing fluorine-free photoacid generators are enabled as alternatives to PFOS/PFAS photoacid generator-containing photoresists. The photoacid generators are characterize...  
WO/2009/091704A2
Fluorine-free photoacid generators and photoresist compositions containing fluorine-free photoacid generators are enabled as alternatives to PFOS/PFAS photoacid generator-containing photoresists. The photoacid generators are characterize...  
WO/2009/087981A1
Disclosed is a polymerizable compound which can be obtained by a simpler process. The polymerizable compound is represented by formula (1) or (2). [Rf-{R1-X0-(CO)t-R2-}q]mX1-R3-Z (1) Rf-R1-X2-CO(NH)r-R3-Z (2) In the formulae, Rf represen...  
WO/2009/081789A1
A compound that is useful as an agent in the prevention and treatment of circulatory system, nervous system, metabolic, reproductive system, and gastrointestinal diseases. Formula (I) is a compound represented by the following: [structur...  
WO/2009/078268A1
Disclosed is a gelling agent containing a fluoroalkyl derivative, a small amount of which can gelatinize or solidify various organic solvents. Specifically disclosed is a gelling agent for organic liquids, which contains a fluoroalkyl de...  
WO/2009/073592A3
The present invention provides fluoroalkyl amines represented by the formula R1-Q-S(O)x-C(H),(CH3)r(CH2)z+(1-1)-NHR and fluoroalkyl isocyanates and isothiocyanates represented by the formula RrQ-S(O)x-C(H)l(CH3)r(CH2)Z+(1-1)-N=C=X1, wher...  
WO/2009/072002A3
The present invention generally relates to anticancer agents and methods of treating cancer. The anticancer agents described herein comprise a bisphenol core and generally act as topoisomerase II inhibitors, though their anticancer activ...  
WO/2009/073592A2
The present invention provides fluoroalkyl amines represented by the formula R1-Q-S(O)x-C(H),(CH3)r(CH2)z+(1-1)-NHR and fluoroalkyl isocyanates and isothiocyanates represented by the formula RrQ-S(O)x-C(H)l(CH3)r(CH2)Z+(1-1)-N=C=X1, wher...  
WO/2009/070873A1
Substituted 2-naphthoic acids of structural formula I are effective as antagonists of the biological activity of GPR105 protein. They are useful for the treatment, control or prevention of disorders responsive to antagonism of this recep...  
WO/2009/066952A1
Provided are a monomer for a proton-conducting polymer having an acid group in aside chain thereof, a proton-conducting polymer prepared using the monomer, a method of preparing the proton-conducting polymer, an electrolyte membrane comp...  
WO/2009/063427A1
Compounds that may have anti-inflammatory activity have the general formula (I): Wherein R1, R2, R3 are each independently H or a C1-4 alkyl group or a C2-4 acyl group; R4 and R5 are each independently H or a group of formula -SO3R6, whe...  
WO/2009/061744A2
Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS), Kearns-Sayre Syndrome (K...  
WO/2009/061744A3
Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS), Kearns-Sayre Syndrome (K...  
WO/2009/049961A2
The present invention refers to new NO-donors aspirin derivatives, a process for their preparation and pharmaceutical compositions containing them.  
WO/2009/049845A2
Novel aromatic compounds of formula (I): wherein A1, A2, A3, A4, R1, R2, R5, G1, G2, Q1, Q2, Y1, Y2, Y3 and Y4 are as defined in claim 1; or a salt or N-oxide thereof. Furthermore, the present invention relates to processes for preparing...  
WO/2009/049961A3
The present invention refers to new NO-donors aspirin derivatives, a process for their preparation and pharmaceutical compositions containing them.  
WO/2009/049845A3
Novel aromatic compounds of formula (I): wherein A1, A2, A3, A4, R1, R2, R5, G1, G2, Q1, Q2, Y1, Y2, Y3 and Y4 are as defined in claim 1; or a salt or N-oxide thereof. Furthermore, the present invention relates to processes for preparing...  
WO/2009/045488A3
The invention encompasses crystalline forms of armodafinil, processes for preparing the crystalline forms of armodafinil, pharmaceutical formulation thereof, and method of treating excessive sleepiness using the formulations of the inven...  
WO/2009/045488A2
The invention encompasses crystalline forms of armodafinil, processes for preparing the crystalline forms of armodafinil, pharmaceutical formulation thereof, and method of treating excessive sleepiness using the formulations of the inven...  
WO/2009/043784A1
Compounds of the formula (I) wherein Ar1, Ar2, R1 and R2 are as defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the subject compounds.  
WO/2009/040590A1
For the manufacturing of a complex product with advanced assimilation efficacy, including methyl-methionine sulphonium, carboxyl-uracil, paraaminobenzoic acid, dimethyl-sulfoxide and poliethoxy castor oil, and its utilization.  
WO/2009/038463A1
The invention relates to new, highly efficient UV - absorbing compounds, a process for their manufacturing and to uses of these UV - absorbing compounds. The UV - absorbing compounds are in particular UV - A - absorbing compounds accordi...  
WO/2009/030752A1
The present invention relates to compounds of formula (I) : as well as to cosmetic and pharmaceutical compositions containing such a compound.  
WO/2009/027004A1
The invention relates to a novel thermodynamically stable crystal modification of 2-({2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)me thyl]phenyl}carbonyl)cyclohexane-1,3-dione. A thermodynamically stable crystal modification of...  
WO/2009/024863A3
Disclosed herein is a convenient, commercially viable and environmentally friendly process for the preparation of Armodafinil. The present invention also provides an improved, commercially viable and industrially advantageous process for...  
WO/2009/025791A2
The invention encompasses processes for obtaining pure armodafinil substantially free of disulfide impurities that is suitable for use on an industrial scale. In particular, a processes for purifying armodafinil from bis(diphenylmethyl)d...  
WO/2009/024863A2
Disclosed herein is a convenient, commercially viable and environmentally friendly process for the preparation of Armodafinil. The present invention also provides an improved, commercially viable and industrially advantageous process for...  
WO/2009/025791A3
The invention encompasses processes for obtaining pure armodafinil substantially free of disulfide impurities that is suitable for use on an industrial scale. In particular, a processes for purifying armodafinil from bis(diphenylmethyl)d...  
WO/2009/022681A1
Disclosed is a positive resist composition which is good in pattern shape, line-edge roughness, pattern collapse, sensitivity and resolution in conventional exposure (dry exposure), liquid immersion exposure and double exposure. Also dis...  
WO/2009/018824A1
A composition comprising specific beta-blockers such as bisoprolol and nebivolol for the treatment of insomnia and/or another sleep disorder. The composition should be given in such an amount that it causes a less than 40 % decrease in t...  
WO/2009/014268A1
There is provided a fluorine-containing organosulfur compound having an excellent controlling effect on arthropod pests represented by the formula (I): wherein G represents an oxygen atom or a sulfur atom; R2 represents a C1-C4 chain hyd...  
WO/2009/010156A2
The invention relates to compounds of formula (I) or the salts thereof, wherein Q is a (hetero)aromatic radical having up to 6 ring atoms, the ring of the heteroaromatic radical comprising 1, 2, 3 or 4 nitrogen atoms or 1 sulphur atom or...  
WO/2009/010156A3
The invention relates to compounds of formula (I) or the salts thereof, wherein Q is a (hetero)aromatic radical having up to 6 ring atoms, the ring of the heteroaromatic radical comprising 1, 2, 3 or 4 nitrogen atoms or 1 sulphur atom or...  
WO/2009/009041A3
The invention relates to compounds and methods for modulating one or more components of a kinase cascade.  

Matches 451 - 500 out of 10,762